The functional activation of GAPT can be influenced by a range of chemical compounds through various signaling pathways. For instance, direct stimulation of specific enzymatic activity within cells can result in elevated levels of secondary messengers, such as cAMP, which play a pivotal role in the modulation of signaling cascades that GAPT is a part of. Activation of G-protein coupled receptors (GPCRs) by certain endogenous ligands leads to an increase in cAMP, and this heightened intracellular concentration of cAMP can enhance GAPT signaling. This is because GAPT is intimately connected with cAMP-responsive elements within the cell, and an increase in this secondary messenger can trigger downstream effects, including the activation of GAPT. Furthermore, the inhibition of enzymes responsible for the breakdown of these secondary messengers also results in their accumulation, thereby potentiating the signaling pathways that culminate in GAPT activation.
Additionally, various neurotransmitters and bioactive molecules bind to their respective receptors, triggering intracellular signaling cascades that may indirectly lead to GAPT activation. For example, the activation of receptors by catecholamines and other neurotransmitters can lead to the production of intracellular messengers, altering calcium levels and other signaling molecules that are critical for GAPT function. These signaling events are crucial as they can modify the activity of GAPT through changes in the intracellular environment that favor the protein's active state. The binding of molecules to ion channel-linked receptors and GPCRs can also influence the activity of downstream kinases and phosphatases, which can have a direct impact on GAPT activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A synthetic catecholamine that acts as an agonist of beta-adrenergic receptors, increasing cAMP and thereby potentially activating cAMP-dependent pathways influencing GAPT. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Binds to prostaglandin receptors, which can lead to an increase in cAMP production, indirectly promoting GAPT signaling through cAMP-responsive elements. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-specific inhibitor of phosphodiesterases, preventing cAMP breakdown, which could support the activation of GAPT through elevated cAMP levels. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Acts on alpha and beta-adrenergic receptors, leading to increased cAMP levels, possibly enhancing GAPT signaling via cAMP-dependent pathways. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Activates G-protein coupled histamine receptors, which can result in altered intracellular signaling cascades that may indirectly increase GAPT activity. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Binds to G-protein coupled receptors, influencing multiple signaling pathways, including those that could upregulate GAPT signaling. | ||||||
3-(2-Aminoethyl)-1H-indol-5-ol | 50-67-9 | sc-298707 | 1 g | $530.00 | 3 | |
Acts on serotonin receptors, potentially modulating signal transduction pathways that could enhance GAPT activity. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Binds dopamine receptors, which may activate signaling pathways that indirectly lead to the functional activation of GAPT. | ||||||